France Community Oncology service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Community Oncology Services is expanding as a result of increasing prevalence of cancer in both developing and developed countries. Advancements in diagnostic devices and methods for cancer, treatment modalities and telemedicine are also driving the growth of Community Oncology service market globally. Some of the key players in the global Community Oncology Service Market McKesson Corporation, F. Hoffmann-La Roche AG, Novartis International AG, Bristol-Myers Squibb, Amgen Inc., Merck & Co., Inc., AstraZeneca plc, Pfizer Inc., Johnson & Johnson, and Eli Lilly and Company.
France Community Oncology service Market is valued at around $1.66 Bn in 2022 and is projected to reach $2.5 Bn by 2030, exhibiting a CAGR of 5.2% during the forecast period 2023-2030.
The Community Oncology Service Market refers to the market for procedures or treatment provided for cancer in community settings like outpatient clinics or local hospitals. Community Oncology service includes a variety of services like diagnosis, treatment, supportive care, and survivorship programs for cancer patients.
According to WHO, there were around 19.3 Mn new cases of cancer globally in 2022. There were around 10 Mn deaths caused by cancer globally in 2022 and it is increasing with every passing year. The most common type of cancers in males are lung cancer, prostate cancer, colorectal cancer, and liver cancer. In females, breast cancer, colorectal cancer, lung cancer, cervical cancer, and thyroid cancer are the most common type of cancers. Which are driving the market for community oncology service market.
There are many Community Oncology Services providers in the market but McKesson Corporation, F. Hoffmann-La Roche AG, Novartis International AG, Bristol-Myers Squibb, Amgen Inc., Merck & Co., Inc., AstraZeneca plc, Pfizer Inc., Johnson & Johnson, and Eli Lilly and Company are some of the major players in the market.
Investments are increasing in Community Oncology Service Market, leading to advancements in technologies like telemedicine, remote patient monitoring, electronic data management, and procedures like precision medicine, immunotherapy advancements, and genomic profiling. It has increased the growth of the Community Oncology Service Market.
Increasing incidence of cancer, advancement in treatment and technology, and rising knowledge of Community Oncology Services are projected to fuel the market for Community Oncology Services in coming years. The market still has many difficulties including the high cost of treatment, treatment risk and uncertainty, lack of skilled professionals, and complex regulatory procedures.
Drivers of France Community Oncology Service Market:
Increasing Prevalence of Cancer: The prevalence of cancer is increasing worldwide and it is driving a market for community oncology services. Lifestyle changes, the aging population, and environmental factors are major drivers for increasing cancer cases and it is creating high demand for oncology services.
Advancement in Cancer Treatment: As technology improves it makes it possible to provide more efficient and effective services. There have been many technological advancements in the treatment and diagnosis of cancer like immunotherapies, targeted therapies, and precision medicine which has given a boost to the community oncology service market.
Growing Awareness: People are becoming more aware and accepting the Community Oncology treatment. People are becoming more conscious about regular screening for cancer symptoms, and the advantages of early detection of cancer. Education campaigns, public discussions, and sharing of personal experiences have helped in increasing awareness and Early diagnosis of cancer has improved a treatment outcome. It has driven the growth of the Community Oncology service market.
Technological Advancements: Remote patient monitoring, telehealth, electronic health records, and other technological advancements have transformed cancer treatment delivery and given a boost to the community oncology service market. It has improved patient engagement and coordination as well as enabled remote consultations.
Restraints of France Community Oncology Service Market:
Limited Access to Specialized Care: Limited healthcare infrastructure and resources can result in a lack of specialized care in remote areas. It can sometimes lead to delayed diagnosis, and lack of treatment options affecting the patient outcome.
Shortage of Specialized Healthcare Professionals: There is a shortage of oncology specialists and nursing staff with adequate knowledge of oncology. Demand for oncology services is more than the availability of workers, it has increased waiting time and compromised the quality of care.
Regulatory Challenges: Regulatory process is complex to enter the market and it takes time and high cost. It is challenging to manage documentation, regulatory processes, and reimbursement procedures which take time and impact the efficiency of services.
In 2022, New recommendations for the use of telemedicine in cancer therapy were published by the American Society of Clinical Oncology (ASCO). These recommendations make it simpler for oncologists to treat patients who live in remote or underserved locations via telemedicine.
In 2022, the FDA authorized the first CAR T-cell therapy to manage leukemia. Immunotherapy, such as CAR T-cell treatment, fights cancer by using the patient's own immune system. The way cancer is handled could change thanks to this new therapy.
In 2022, the Centers for Medicare and Medicaid Services (CMS) declared the implementation of a new value-based payment scheme for community oncology practitioners. By offering high-quality treatment at a lesser cost, this approach will compensate the providers.
Key players
Institut Curie Gustave Roussy Cancer Campus Centre L?on B?rard Centre Georges-Fran?ois Leclerc Centre L?on B?rard Centre Paul Strauss Centre Eug?ne Marquis Institut Paoli-Calmettes Centre Oscar Lambret Centre Fran?ois Baclesse1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type:
By Cancer:
By Therapy:
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.